Health Care & Life Sciences » Biotechnology | Sprint Bioscience AB

Sprint Bioscience AB

Sprint Bioscience AB
Stock Exchange First North Sweden
EPS
 SEK1.75
Market Cap
 SEK189.88 M
Shares Outstanding
 10.1 M
Public Float
 -

Profile

Address
Hälsovägen 7
Huddinge AB 141 57
Sweden
Employees -
Website http://www.sprintbioscience.com
Updated 09/14/2018
Sprint Bioscience AB engages in the business of drug development. It develops medicines in the field of cancer and metabolism. The company serves as preclinical part of the development process.

Financials

View All
Created with Highcharts 5.0.14Sprint Bioscience ABNet Income. Fiscal year is January-December. All values SEK Thousands.11 46311 46315 50015 5004 5404 54010 66310 663201420152016201705k10k15k20k
Created with Highcharts 5.0.14Sprint Bioscience ABSales/Revenue. Fiscal year is January-December. All values SEK Thousands.007 7267 72634 99234 99223 96723 9672014201520162017010k20k30k40k

Ingemar Kihlström
Director
Charlotta Liljebris
Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.